The role of INI1 and the SWI/SNF complex in the development of rhabdoid tumors: Meeting summary from the workshop on childhood atypical teratoid/rhabdoid tumors

Cancer Research

Volumn 62, Issue 1, 2002, Pages 323-328

  Biegel, Jaclyn A ^a   Kalpana, Ganjam ^b   Knudsen, Erik S ^c   Packer, Roger J ^d   Roberts, Charles W M ^e   Thiele, Carol J ^f   Smith, Malcolm ^f   Weissman, Bernard ^g  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^d CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^e DANA FARBER CANCER INSTITUTE   (United States)

^f NATIONAL CANCER INSTITUTE   (United States)

^g UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MARROW TRANSPLANTATION; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER RADIOTHERAPY; CARCINOGENESIS; CENTRAL NERVOUS SYSTEM; CHILDHOOD CANCER; CONFERENCE PAPER; GENE DELETION; HUMAN; NONHUMAN; PRIORITY JOURNAL; RHABDOID TUMOR; STEM CELL TRANSPLANTATION; TERATOMA; TUMOR SUPPRESSOR GENE; WORKSHOP;

CENTRAL NERVOUS SYSTEM NEOPLASMS; CHROMOSOMAL PROTEINS, NON-HISTONE; DNA-BINDING PROTEINS; DROSOPHILA PROTEINS; HUMANS; RHABDOID TUMOR; RIBONUCLEOPROTEIN, U1 SMALL NUCLEAR; RNA-BINDING PROTEINS; TRANSCRIPTION FACTORS;

EID: 0036141494     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (69)

1. Atypical teratoid tumor of infancy: Definition of an entity
2. Monosomy 22 in rhabdoid or atypical tumors of the brain
3. Atypical teratoid/rhabdoid tumor of the central nervous system: A highly malignant tumor of infancy and childhood frequently mistaken for medulloblastoma: A Pediatric Oncology Group study
4. Central nervous system atypical teratoid/rhabdoid tumors of infancy and childhood: Definition of an entity
5. Truncating mutations of hSNF5/INI1 in aggressive paediatric cancer
6. Germ-line and acquired mutations of INI1 in atypical teratoid and rhabdoid tumors
7. hSNF5/INI1 inactivation is mainly associated with homozygous deletions and mitotic recombinations in rhabdoid tumors
8. Constitutional mutations of the hSNF5/INI1 gene predispose to a variety of cancers
9. c-MYC interacts with INI1/hSNF5 and requires the SWI/SNF complex for transactivation function
10. Structure-function analysis of integrase interactor 1/hSNF5L1 reveals differential properties of two repeat motifs present in the highly conserved region
11. The mammalian SWI/SNF complex and the control of cell growth
12. SWI/SNF complex: Dissection of a chromatin remodeling cycle
13. Human SWI/SNF interconverts a nucleosome between its base state and a stable remodeled state
14. A model for chromatin remodeling by the SWI/SNF family
15. Transcriptional regulation: SWitching circuitry
16. BRG1 contains a conserved domain of the SWI2/SNF2 family necessary for normal mitotic growth and transcription
17. The yeast SNF2/SWI2 protein has DNA-stimulated ATPase activity required for transcriptional activation
18. Purification and biochemical heterogeneity of the mammalian SWI-SNF complex
19. Diversity and specialization of mammalian SWI/SNF complexes
20. Binding and stimulation of HIV-1 integrase by a human homolog of yeast transcription factor SNF5
21. Reconstitution of a core chromatin remodeling complex from SWI/SNF subunits
22. The yeast SWI-SNF complex facilitates binding of a transcriptional activator to nucleosomal sites in vivo
23. DNA-binding properties of the yeast SWI/SNF complex
24. Proteins of the Myc network: Essential regulators of cell growth and differentiation
25. Role for N-CoR and histone deacetylase in Sin3-mediated transcriptional repression
26. Histone deacetylases associated with the mSin 3 corepressor mediate mad transcriptional repression
27. Leukemic HRX fusion proteins inhibit GADD34-induced apoptosis and associate with the GADD34 and hSNF5/INI1 proteins
28. Interaction of E1 and hSNF5 proteins stimulates replication of human papillomavirus DNA
29. The C-terminal SET domains of ALL-1 and TRITHORAX interact with the INI1 and SNRI proteins, components of the SWI/SNF complex
30. Epstein-Barr virus nuclear protein 2 (EBNA2) binds to a component of the human SNF-SWI complex, hSNF5/Ini1
31. Haploinsufficiency of Snf5 (integrase interactor 1) predisposes to malignant rhabdoid tumors in mice
32. The murine SNF5/INI1 chromatin remodeling factor is essential for embryonic development and tumor suppression
33. BRGI, a component of the SWI-SNF complex, is mutated in multiple human tumor cell lines
34. A Brgl null mutation in the mouse reveals functional differences among mammalian SWI/SNF complexes
35. The retinoblastoma gene: A prototypic and multifunctional tumor suppressor
36. The Rb/E2F pathway: Expanding roles and emerging paradigms
37. The retinoblastoma protein pathway in cell cycle control and cancer
38. Cancer cell cycles
39. BRG-I is required for RB-mediated cell cycle arrest
40. Restoration of retinoblastoma mediated signaling to Cdk2 results in cell cycle arrest
41. 1/S transition and S-phase progression
42. The retinoblastoma tumor suppressor inhibits cellular proliferation through two distinct mechanisms: Inhibition of cell cycle progression and induction of cell death
43. The retinoblastoma protein and BRGI form a complex and cooperate to induce cell cycle arrest
44. Functional interactions between the hBRM/hBRGI transcriptional activators and the pRB family of proteins
45. 1 and S phase of the cell cycle is regulated by repressor complexes containing HDAC-Rb-hSWI/SNF and Rb-hSWI/SNF
46. Chemotherapy compared with autologous or allogeneic bone marrow transplantation in the management of acute myeloid leukemia in first remission
47. RB-dependent S-phase response to DNA damage
48. The BRG-1 subunit of the SWI/SNF complex regulates CD44 expression
49. The CD44 proteins in embryonic development and in cancer
50. CD44 cell adhesion molecules
51. How tumor cells make use of CD44
52. CD44: Structure, function, and association with the malignant process
53. Histone acetylation and chromatin remodeling
54. The Swi/Snf family nucleosome-remodeling complexes and transcriptional control
55. Role of histone deacetylase complexes in the regulation of chromatin metabolism
56. A novel nuclear receptor corepressor complex, N-CoR, contains components of the mammalian SWI/SNF complex and the corepressor KAP-1
57. Purification and characterization of mSin3A-containing Brg1 and hBrm chromatin remodeling complexes
58. Whole-genome expression analysis of snf/swi mutants of Saccharomyces cerevisiae
59. Histone deacetylase inhibitors: Inducers of differentiation or apoptosis of transformed cells
60. 1 arrest with downregulation of cyclin DI and upregulation of cyclin E by the histone deacetylase inhibitor FR901228
61. MS-275, a histone deacetylase inhibitor, selectively induces transforming growth factor β type 11 receptor expression in human breast cancer cells
62. Hybrid polar histone deacetylase inhibitor induces apoptosis and CD95/CD95 ligand expression in human neuroblastoma
63. The histone deacetylase inhibitor and chemotherapeutic agent suberoylanilide hydroxamic acid (SAHA) induces a cell-death pathway characterized by cleavage of Bid and production of reactive oxygen species
64. Role of the histone deacetylase complex in acute promyelocytic leukaemia
65. Amino acid substitutions in the structured domains of histones H3 and H4 partially relieve the requirement of the yeast SWI/SNF complex for transcription
66. Effects of Sinversions of histone H4 on yeast chromatin structure and function
67. Sin mutations of histone H3: Influence on nucleosome core structure and function
68. The Max network gone mad
69. A synthetic inhibitor of histone deacetylase, MS-27-275, with marked in vivo antitumor activity against human tumors